Skylands Capital’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-16,150
Closed -$279K 200
2015
Q4
$279K Sell
16,150
-10,650
-40% -$154K 0.04% 169
2015
Q3
$326K Sell
26,800
-20,400
-43% -$262K 0.04% 176
2015
Q2
$569K Sell
47,200
-10,100
-18% -$99.4K 0.06% 180
2015
Q1
$480K Sell
57,300
-9,900
-15% -$77.7K 0.05% 187
2014
Q4
$514K Hold
67,200
0.05% 181
2014
Q3
$462K Buy
67,200
+14,600
+28% +$109K 0.05% 196
2014
Q2
$435K Buy
+52,600
New +$411K 0.04% 198

Other funds holding LMAT

Skylands Capital's LMAT Position: Q1 2016 in Review

Skylands Capital sold out of LeMaitre Vascular (LMAT) in Q1 2016, closing a stake of 16,150 shares — an estimated $279K sold.

Skylands Capital first reported a position in LMAT in Q2 2014 and held it in 7 quarters. The position peaked at $569K in Q2 2015. 95 funds tracked by Wall St. Rank hold LMAT as of Q1 2016.

  • Skylands Capital reported no remaining LeMaitre Vascular position as of Q1 2016 after selling out during the quarter.
  • Skylands Capital sold 16,150 LeMaitre Vascular shares in Q1 2016, an estimated $279K.
  • Skylands Capital first reported a position in LeMaitre Vascular in Q2 2014 and held it in 7 quarters.
  • Skylands Capital's LeMaitre Vascular position peaked at $569K in Q2 2015.
  • 95 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2016.

Based on Skylands Capital's 13F filing for Q1 2016, filed 14 Apr 2016.